Recent Finacing
Recent Raise
Rodeo Therapeutics is a biopharma developing small-molecule 15-PGDH inhibitors to raise PGE2 levels and promote tissue regeneration, targeting inflammatory bowel disease and hematopoietic reconstitution after bone marrow transplant.
